Fred Hutchinson Cancer Center clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 546 studies whose lead sponsor is Fred Hutchinson Cancer Center. 79 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.
Keep track of what changes. Save the Fred Hutchinson Cancer Center studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Fred Hutchinson Cancer Center leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Leukemia140Myelodysplastic Syndromes108Lymphoma87Leukemia, Myeloid, Acute84Precursor Cell Lymphoblastic Leukemia-Lymphoma71Multiple Myeloma67Leukemia, Lymphocytic, Chronic, B-Cell56Lymphoma, Non-Hodgkin56Leukemia, Myelogenous, Chronic, BCR-ABL Positive50Lymphoma, Mantle-Cell46Myeloproliferative Disorders46Lymphoma, Large B-Cell, Diffuse45Lymphoma, B-Cell42Myelodysplastic-Myeloproliferative Diseases37Burkitt Lymphoma34Hodgkin Disease34Lymphoma, Follicular33Breast Neoplasms32Waldenstrom Macroglobulinemia32Leukemia, Myelomonocytic, Chronic31Lymphoma, B-Cell, Marginal Zone31Graft vs Host Disease28Lymphoma, Large-Cell, Immunoblastic27Neoplasms27
Show all 59 areas
Lymphoma, T-Cell26Plasmablastic Lymphoma25Leukemia, Myelomonocytic, Juvenile24Leukemia, Biphenotypic, Acute22Hematologic Neoplasms21Leukemia, Myeloid, Chronic-Phase21Leukemia, Myeloid, Accelerated Phase20Mycosis Fungoides20Plasmacytoma20Lymphoma, Large-Cell, Anaplastic19Lymphomatoid Granulomatosis18Anemia, Refractory, with Excess of Blasts17Blast Crisis17Leukemia, Hairy Cell17Neoplasm Metastasis17Anemia16Lymphoma, Extranodal NK-T-Cell16Melanoma16Leukemia-Lymphoma, Adult T-Cell15Leukemia, Prolymphocytic15Lymphoma, T-Cell, Peripheral15Sarcoma15Immunoblastic Lymphadenopathy14Leukemia, Myelomonocytic, Acute14Anemia, Refractory13Carcinoma13Intraocular Lymphoma13Lung Neoplasms13Primary Myelofibrosis13Bronchiolitis Obliterans Syndrome12Prostatic Neoplasms12Colorectal Neoplasms11Infections10Leukemia, Erythroblastic, Acute10Leukemia, Large Granular Lymphocytic10
Studies
Recruiting first, then most recently updated. Showing 50 of 546. Browse all 546 →
- Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 TrialRecruitingNCT04941716Phase 2
- Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial CancerRecruitingNCT07667335Phase 1/2
- Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT TrialRecruitingNCT07052630Not applicable
- Dental Cleaning to Prevent Chronic Graft-Versus-Host DiseaseRecruitingNCT07535008Not applicable
- Tacabrutideg and Sonrotoclax, With Response-Guided Obinutuzumab, for the Treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Not yet recruitingNCT07887061Phase 2
- A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT TrialRecruitingNCT06771739Not applicable
- Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)RecruitingNCT03970096Phase 2
- A Smartphone Application (QuitBot) for the Improvement of Smoking Cessation Among American Indians and Alaska Natives, NAITIVE TrialNot yet recruitingNCT06697496Not applicable
- T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon CancerRecruitingNCT06043713Phase 1
- Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 KenyaRecruitingNCT07468695Not applicable
- Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South AfricaRecruitingNCT07645378Not applicable
- Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic CancersRecruitingNCT07731880
- Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap SyndromesRecruitingNCT07228624Phase 2
- Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 RwandaRecruitingNCT07390916Not applicable
- Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 ZimbabweRecruitingNCT07645352Not applicable
- Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid NeoplasmsRecruitingNCT07094750Not applicable
- Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP TrialRecruitingNCT07466498Phase 2
- An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS TrialRecruitingNCT07615764Not applicable
- Testing Pasritamig Before Surgery for the Treatment of Localized Prostate CancerNot yet recruitingNCT07860255Phase 1
- Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised IndividualsRecruitingNCT06817889Phase 2
- Tele-HOPE: A Telehealth Pharmacist Opioid Patient Education Pilot StudyNot yet recruitingNCT07737314Not applicable
- Axatilimab for Sclerotic Chronic Graft-versus-Host DiseaseRecruitingNCT07011810Phase 2
- iCanQuit Smoking Cessation Among Hispanic AdultsNot yet recruitingNCT06811038Phase 3
- Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS TrialRecruitingNCT07176000Not applicable
- Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host DiseaseRecruitingNCT05996627Phase 2
- CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaRecruitingNCT04375631Phase 1
- Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV TrialRecruitingNCT06926062Not applicable
- Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant PatientsNot yet recruitingNCT07390968Phase 2
- Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNot yet recruitingNCT07576725Phase 2
- A Spiritual Health Intervention (PATH) for Improving Spiritual, Religious and Emotional Distress in Cancer PatientsNot yet recruitingNCT07545291Not applicable
- A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE TrialRecruitingNCT07490860Not applicable
- FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaRecruitingNCT07645469Phase 1
- Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant DisordersRecruitingNCT03980769Phase 2
- Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple MyelomaRecruitingNCT07181941Phase 1/2
- Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic SyndromeNot yet recruitingNCT07819396Phase 2
- Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host DiseaseRecruitingNCT05067595Phase 1
- Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecruitingNCT07194980Phase 2
- A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette UsersRecruitingNCT06909500Not applicable
- IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT07803653Phase 1
- A Novel Smartphone Application for Helping Teens Stop Vaping, QuitQuest Vaping R01Not yet recruitingNCT07739706Not applicable
- Sustained Oral Fiber Supplementation for Patients Undergoing Treatment for Hematological MalignanciesRecruitingNCT04829136Not applicable
- Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web EducationRecruitingNCT06995924Not applicable
- Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe TrialRecruitingNCT07227571Phase 1
- Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support PersonRecruitingNCT07141407Not applicable
- Effect of Meal Timing During Adjuvant Treatment for CancerRecruitingNCT07524218Not applicable
- A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit TrialRecruitingNCT06145763Not applicable
- High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO TrialRecruitingNCT06298734Not applicable
- Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and DementiaRecruitingNCT06922188
- Mobile Health Application (PACT) to Improve Engagement in Advance Care PlanningRecruitingNCT04515810Not applicable
- Rifaximin Versus No Intervention for the Treatment of IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined SignificanceRecruitingNCT07209371Phase 2